Jump to main content
Jump to site search

Issue 30, 2012
Previous Article Next Article

Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)

Author affiliations

Abstract

The development of novel peptide and peptidomimetic ligands for the CXC chemokine receptor 4 (CXCR4) as therapeutic agents for HIV-1 infection, cancer, and immune system diseases has grown over the last decade. In this perspective article, the design of CXCR4 agonists and antagonists from endogenous stromal cell-derived factor-1 (SDF-1)/CXCL12 and horseshoe crab-derived antimicrobial peptides and their therapeutic and diagnostic applications are described.

Graphical abstract: Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 14 Jan 2012, accepted on 16 Mar 2012 and first published on 19 Mar 2012


Article type: Perspective
DOI: 10.1039/C2OB25107H
Citation: Org. Biomol. Chem., 2012,10, 5720-5731
  •   Request permissions

    Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)

    S. Oishi and N. Fujii, Org. Biomol. Chem., 2012, 10, 5720
    DOI: 10.1039/C2OB25107H

Search articles by author